Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,961Revenue (TTM) $M78.6Net Margin (%)-216.5Altman Z-Score27.6
Enterprise Value $M1,644EPS (TTM) $-1.7Operating Margin %-218.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.3Pre-tax Margin (%)-216.5Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %13.9Quick Ratio11.7Cash flow > EarningsY
Price/Sales22.95-y EBITDA Growth Rate %36.8Current Ratio11.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-47.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-53.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M108ROIC % (ttm)-615.3Gross Margin Increase y-yY

Gurus Latest Trades with EXAS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXASJoel Greenblatt 2016-09-30 Add0.01%$11.86 - $21.49
($17.62)
$ 18.093%Add 201.39%53,252
EXASJoel Greenblatt 2016-06-30 Buy $5.46 - $12.25
($7.52)
$ 18.09141%New holding17,669
EXASGeorge Soros 2014-06-30 Sold Out -0.03%$11.17 - $17.27
($13.72)
$ 18.0932%Sold Out0
EXASGeorge Soros 2014-03-31 Buy 0.03%$11.75 - $14.82
($13.45)
$ 18.0934%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXAS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EXAS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COWARD D SCOTTSVP and General Counsel 2017-01-03Sell1,535$13.6132.92view
THOMPSON DAVIDDirector 2016-12-14Buy10,000$13.8430.71view
LIDGARD GRAHAM PETERChief Science Officer 2016-11-15Sell311,112$17.463.61view
Conroy Kevin TPresident and CEO 2016-11-15Sell600,000$17.463.61view
ARORA MANEESHCOO 2016-11-15Sell562,932$17.463.61view
Sterling LionelDirector 2016-09-01Buy5,000$18.1-0.06view
Zanotti Katherine SDirector 2016-08-03Buy3,380$17.930.89view
LIDGARD GRAHAM PETERChief Science Officer 2016-07-26Sell7,383$14.8222.06view
ARORA MANEESHCOO 2016-07-26Sell7,359$14.8222.06view
COWARD D SCOTTSVP and General Counsel 2016-04-01Sell1,685$6.62173.26view

Press Releases about EXAS :

Quarterly/Annual Reports about EXAS:

News about EXAS:

Articles On GuruFocus.com
Whitney Tilson's Robin Hood Conference Presentation Nov 19 2015 
Why I'm Short Exact Sciences - Whitney Tilson Presentation Feb 24 2015 
Weekly CEO Sells Highlight: Exact Sciences Corp Zayo Group Holdings Inc, Western Alliance Bancorp, a Oct 27 2014 
Meridian Funds Comments on Exact Sciences Corp Jun 20 2014 
Weekly CEO Buys Highlight: BFS, FL, BGC, AMCF, and EXAS Nov 28 2010 
EXACT Sciences Corp. (EXAS) CEO Kevin T Conroy buys 6,000 Shares Nov 23 2010 
EXACT Sciences Corp. (EXAS) CFO Maneesh Arora buys 2,500 Shares Aug 20 2010 
Weekly CFO Buys Highlight: Heska Corp., Apollo Investment Corp., EXACT Sciences Corp., Innospec Inc. Feb 28 2010 

More From Other Websites
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees Jan 13 2017
Exact Sciences Q4 Sales Beat, Colon-Cancer Test Procedures Double Jan 09 2017
ETFs with exposure to EXACT Sciences Corp. : January 9, 2017 Jan 09 2017
EXACT Sciences Corp. – Value Analysis (NASDAQ:EXAS) : January 9, 2017 Jan 09 2017
Stocks Mixed, Nasdaq Up; Apple Breaks Out Past New Buy Point Jan 09 2017
Diagnosing colon cancer in the privacy of your own home Jan 09 2017
Exact Sciences to report $99 million in revenues, 150 percent growth for 2016 Jan 08 2017
EXACT Sciences Corp. breached its 50 day moving average in a Bullish Manner : EXAS-US : January 6,... Jan 06 2017
Cologuard Earns Positive Review from Blue Cross Blue Shield Association Jan 05 2017
Biotech Stocks to Watch in 2017 Enanta Pharmaceuticals and EXACT Sciences Jan 04 2017
Exact Sciences to participate in J.P. Morgan Healthcare Conference Jan 03 2017
New Strong Buy Stocks for December 29th Dec 29 2016
Exact Sciences (EXAS): Strong Industry, Solid Earnings Estimate Revisions Dec 16 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)